ESERX
Price
$34.03
Change
-$0.40 (-1.16%)
Updated
Nov 13 closing price
Net Assets
593.38M
RGACX
Price
$84.05
Change
-$1.88 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

ESERX vs RGACX

Header iconESERX vs RGACX Comparison
Open Charts ESERX vs RGACXBanner chart's image
Eaton Vance Atlanta Capital Sel Eq R6
Price$34.03
Change-$0.40 (-1.16%)
VolumeN/A
Net Assets593.38M
American Funds Growth Fund of Amer R3
Price$84.05
Change-$1.88 (-2.19%)
VolumeN/A
Net Assets340.4B
ESERX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
ESERX vs. RGACX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESERX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 340B vs. ESERX (593M). RGACX pays higher dividends than ESERX: RGACX (0.07) vs ESERX (0.00). ESERX was incepted earlier than RGACX: ESERX (9 years) vs RGACX (24 years). RGACX (0.94) is less costly to investors than ESERX (0.75). RGACX is a more actively managed with annual turnover of: 25.00 vs. ESERX (2.00). RGACX has a lower initial minimum investment than ESERX: RGACX (250) vs ESERX (5000000). RGACX annual gain was more profitable for investors over the last year : 8.31 vs. ESERX (-11.19). RGACX return over 5 years is better than : 37.90 vs. ESERX (13.37).
ESERXRGACXESERX / RGACX
Total Expense Ratio0.750.9480%
Annual Report Gross Expense Ratio0.750.9480%
Fund Existence9 years24 years-
Gain YTD-4.75819.364-25%
Front LoadN/AN/A-
Min. Initial Investment50000002502,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets593M340B0%
Annual Yield % from dividends0.000.07-
Returns for 1 year-11.198.31-135%
Returns for 3 years18.6063.3129%
Returns for 5 years13.3737.9035%
Returns for 10 yearsN/A98.36-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SAEF26.620.11
+0.41%
Schwab Ariel Opportunities ETF
XBI114.110.10
+0.09%
State Street® SPDR® S&P® Biotech ETF
SIXJ33.730.01
+0.02%
AllianzIM US Lrg Cp 6M Bfr10 Jan/Jul ETF
IBTK19.90N/A
N/A
iShares iBonds Dec 2030 Term Trsry ETF
WTIP32.12N/A
N/A
WisdomTree Inflation Plus Fund